Gabapentin
Product Images NDC 10544-436

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 10544-436). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (A58e76e8 0645 4c40 A738 5015e88bd68c 01)

Chemical structure of gabapentin, showing a cyclohexane ring attached to side chains including CH2NH2 and CH2CO2H groups.*

FDA Label Image

Figure 1 (A58e76e8 0645 4c40 A738 5015e88bd68c 02)

Line graph depicting the mean pain score over 8 weeks comparing two groups: placebo and Gabapentin at 3600 mg/day. The graph shows a 4-week dose titration period followed by a 4-week fixed dose period. Gabapentin group exhibits a decreasing mean pain score over time, while placebo remains relatively constant. Statistical significance is indicated with p < 0.01.*

FDA Label Image

Figure 2 (A58e76e8 0645 4c40 A738 5015e88bd68c 03)

A line graph depicting mean pain scores over 7 weeks comparing placebo and two gabapentin dosing groups (1800 mg/day and 2400 mg/day). The x-axis represents weeks from baseline through 7 weeks, divided into a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin groups show a greater reduction in pain score than placebo, with statistical significance indicated (p < 0.01).*

FDA Label Image

Figure 3 (A58e76e8 0645 4c40 A738 5015e88bd68c 04)

A bar chart comparing the percentage of responders at endpoint between placebo (PBO) and gabapentin (GBP) doses in two studies. Study 1 shows 12% responders for PBO and 29% for GBP 3600 mg. Study 2 shows 14% for PBO, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance is indicated with p-values less than 0.01 and 0.001.*

FDA Label Image

Figure 4 (A58e76e8 0645 4c40 A738 5015e88bd68c 05)

A scatter plot graph showing the difference percentage on the y-axis against daily dose in milligrams on the x-axis for Gabapentin. It compares data points from three studies labeled Study a, Study b, and Study c, with different marker styles used for each study across doses of approximately 600, 900, 1200, and 1800 mg.*

FDA Label Image

Label Graphic-gabapentin (blenheim) 300mg 90s (A58e76e8 0645 4c40 A738 5015e88bd68c 06)

Gabapentin Capsules USP 300mg, package containing 90 capsules labeled by Blenheim Pharmacal, Inc. The label includes NDC 10544-436-90 and manufacturer code 60505-0113-8. Storage instructions advise controlled room temperature and protection from light and moisture. The label states Rx only and provides dosing direction to see the package insert.*

FDA Label Image

Label Graphic-gabapentin (blenheim) 400mg 90s (A58e76e8 0645 4c40 A738 5015e88bd68c 07)

Gabapentin Capsules, USP 400mg packaging label shows a bottle label for 90 capsules by Blenheim Pharmacal, Inc. It includes storage instructions, dosage note to see package insert, and a barcode. The label lists the NDC 10544-447-90 and manufacturer number 60505-0114-5 with lot and expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.